Ninety One (UK)
PRAH

Ninety One (UK)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ninety One (UK)’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-39,543
Closed -$4.36M – 286
2019
Q1 		$4.36M Sell
39,543
-9,689
-20% -$1.01M 0.02% 231
2018
Q4 		$4.53M Hold
49,232
– – 0.02% 231
2018
Q3 		$5.42M Sell
49,232
-896
-2% -$93.3K 0.02% 226
2018
Q2 		$4.68M Buy
50,128
+307
+0.6% +$26.4K 0.02% 212
2018
Q1 		$4.13M Buy
49,821
+30,544
+158% +$2.71M 0.02% 202
2017
Q4 		$1.76M Buy
+19,277
New +$1.6M 0.01% 262

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ninety One (UK)'s PRAH Position: Q2 2019 in Review

Ninety One (UK) sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 39,543 shares — an estimated $4.36M sold.

Ninety One (UK) first reported a position in PRAH in Q4 2017 and held it in 6 quarters. The position peaked at $5.42M in Q3 2018. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Ninety One (UK) reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Ninety One (UK) sold 39,543 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $4.36M.
  • Ninety One (UK) first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 6 quarters.
  • Ninety One (UK)'s PRA Health Sciences, Inc. position peaked at $5.42M in Q3 2018.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Ninety One (UK)'s 13F filing for Q2 2019, filed 30 Jul 2019.